Elevated lactate dehydrogenase activity and increased cardiovascular mortality in the arsenic-endemic areas of southwestern Taiwan

Toxicology and Applied Pharmacology

Volumn 262, Issue 3, 2012, Pages 232-237

  Liao, Ya Tang ^a,b,c   Chen, Chien Jen ^b,c   Li, Wan Fen ^a   Hsu, Ling I ^c   Tsai, Li Yu ^d   Huang, Yeou Lih ^d   Sun, Chien Wen ^a   Chen, Wei J ^b   Wang, Shu Li ^a,e  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c GENOMICS RESEARCH CENTER   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Arsenic; Cardiovascular mortality; Lactate dehydrogenase; Liver function tests

Indexed keywords

ARSENIC; LACTATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FRAMINGHAM RISK SCORE; HAZARD RATIO; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LONG TERM EXPOSURE; MALE; TAIWAN; URINALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ARSENIC; CARDIOVASCULAR DISEASES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; MALE; MIDDLE AGED; TAIWAN;

EID: 84863815694     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.04.028     Document Type: Article

References (38)

1. Blackwell R.Q. Estimation total arsenic ingested by residents in the endemic blackfoot area. J Formos. Med. Assoc. 1961, 60:1143-1144.
2. Brancaccio P., Maffulli N., Buonauro R., Limongelli F.M. Serum enzyme monitoring in sports medicine. Clin. Sports Med. 2008, 27:1-18. (vii).
3. Chen W.Y., Chen K.P. Study on Arsenic Artesian Well Water and Blackfoot Disease Progress 1975, Taiwan Provincial Institute of Environmental Sanitation, Taichung, Taiwan.
4. Chen K.P., Wu T.C., Wu T.C. Epidemiologic studies on blackfoot disease in Taiwan. 3. Physicochemical characteristics of drinking water in endemic blackfoot disease areas. Mem. Coll. Med. Natl. Taiwan Univ. 1962, 8:115-129.
5. Chen C.J., Chuang Y.C., Lin T.M., Wu H.Y. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res. 1985, 45:5895-5899.
6. Chen C.J., Hsueh Y.M., Lai M.S., Shyu M.P., Chen S.Y., Wu M.M., Kuo T.L., Tai T.Y. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 1995, 25:53-60.
7. Chen Y., Ahsan H., Slavkovich V., Peltier G.L., Gluskin R.T., Parvez F., Liu X., Graziano J.H. No association between arsenic exposure from drinking water and diabetes mellitus: a cross-sectional study in Bangladesh. Environ. Health Perspect. 2010, 118:1299-1305.
8. Chen Y., Graziano J.H., Parvez F., Liu M., Slavkovich V., Kalra T., Argos M., Islam T., Ahmed A., Rakibuz-Zaman M., Hasan R., Sarwar G., Levy D., van Geen A., Ahsan H. Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study. BMJ 2011, 342:d2431.
9. Chu W.W., Dieter R.S., Stone C.K. A review of clinically relevant cardiac biochemical markers. WMJ 2002, 101:40-48.
10. D'Agostino R.B., Vasan R.S., Pencina M.J., Wolf P.A., Cobain M., Massaro J.M., Kannel W.B. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008, 117:743-753.
11. Davis R.B., Iezzoni L.I., Phillips R.S., Reiley P., Coffman G.A., Safran C. Predicting in-hospital mortality. The importance of functional status information. Med. Care 1995, 33:906-921.
12. Galen R.S., Reiffel J.A., Gambino R. Diagnosis of acute myocardial infarction. Relative efficiency of serum enzyme and isoenzyme measurements. JAMA 1975, 232:145-147.
13. Hopenhayn-Rich C., Biggs M.L., Kalman D.A., Moore L.E., Smith A.H. Arsenic methylation patterns before and after changing from high to lower concentrations of arsenic in drinking water. Environ. Health Perspect. 1996, 104:1200-1207.
14. Hopenhayn-Rich C., Biggs M.L., Smith A.H., Kalman D.A., Moore L.E. Methylation study of a population environmentally exposed to arsenic in drinking water. Environ. Health Perspect. 1996, 104:620-628.
15. Hsueh Y.M., Huang Y.L., Huang C.C., Wu W.L., Chen H.M., Yang M.H., Lue L.C., Chen C.J. Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan. J. Toxicol. Environ. Health A 1998, 54:431-444.
16. Huang Y.K., Tseng C.H., Huang Y.L., Yang M.H., Chen C.J., Hsueh Y.M. Arsenic methylation capability and hypertension risk in subjects living in arseniasis-hyperendemic areas in southwestern Taiwan. Toxicol. Appl. Pharmacol. 2007, 218:135-142.
17. Islam K., Haque A., Karim R., Fajol A., Hossain E., Salam K.A., Ali N., Saud Z.A., Rahman M., Sultana P., Hossain M., Akhand A.A., Mandal A., Miyataka H., Himeno S., Hossain K. Dose-response relationship between arsenic exposure and the serum enzymes for liver function tests in the individuals exposed to arsenic: a cross sectional study in Bangladesh. Environ. Health 2011, 10:64.
18. Karim M.R., Salam K.A., Hossain E., Islam K., Ali N., Haque A., Saud Z.A., Yeasmin T., Hossain M., Miyataka H., Himeno S., Hossain K. Interaction between chronic arsenic exposure via drinking water and plasma lactate dehydrogenase activity. Sci. Total Environ. 2010, 409:278-283.
19. Kuo T.L. Arsenic Content of Artesian Well Water in Endemic Area of Chronic Arsenic Poisoning In Institute of Pathology 1964, 7-13. National Taiwan University.
20. Lo M.C., Hsen Y.C., Lin B.K. Arsenic Content of Underground Water in Taiwan: Second Report 1977, 1-17. Taiwan Provincial Institute of Environmental Sanitation, Taichung, Taiwan.
21. Loffredo C.A., Aposhian H.V., Cebrian M.E., Yamauchi H., Silbergeld E.K. Variability in human metabolism of arsenic. Environ. Res. 2003, 92:85-91.
22. Longnecker M.P. On confounded fishy results regarding arsenic and diabetes. Epidemiology 2009, 20:821-823. (discussion e821-822).
23. Markowski V.P., Currie D., Reeve E.A., Thompson D., Wise J.P. Tissue-specific and dose-related accumulation of arsenic in mouse offspring following maternal consumption of arsenic-contaminated water. Basic Clin. Pharmacol. Toxicol. 2011, 108:326-332.
24. Mazumder D.N. Effect of chronic intake of arsenic-contaminated water on liver. Toxicol. Appl. Pharmacol. 2005, 206:169-175.
25. Navas-Acien A., Sharrett A.R., Silbergeld E.K., Schwartz B.S., Nachman K.E., Burke T.A., Guallar E. Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am. J. Epidemiol. 2005, 162:1037-1049.
26. Navas-Acien A., Silbergeld E.K., Pastor-Barriuso R., Guallar E. Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA 2008, 300:814-822.
27. NRC Arsenic in Drinking Water 1999, National Academy Press, Washington, DC.
28. Paul P.C., Misbahuddin M., Ahmed A.N., Dewan Z.F., Mannan M.A. Accumulation of arsenic in tissues of iron-deficient rats. Toxicol. Lett. 2002, 135:193-197.
29. Peraza M.A., Carter D.E., Gandolfi A.J. Toxicity and metabolism of subcytotoxic inorganic arsenic in human renal proximal tubule epithelial cells (HK-2). Cell Biol. Toxicol. 2003, 19:253-264.
30. Petrick J.S., Ayala-Fierro F., Cullen W.R., Carter D.E., Vasken Aposhian H. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol. 2000, 163:203-207.
31. Saad S.Y., Alkharfy K.M., Arafah M.M. Cardiotoxic effects of arsenic trioxide/imatinib mesilate combination in rats. J. Pharm. Pharmacol. 2006, 58:567-573.
32. Smith A.H., Hopenhayn-Rich C., Bates M.N., Goeden H.M., Hertz-Picciotto I., Duggan H.M., Wood R., Kosnett M.J., Smith M.T. Cancer risks from arsenic in drinking water. Environ. Health Perspect. 1992, 97:259-267.
33. Tajima H., Yoshida T., Ohnuma A., Fukuyama T., Hayashi K., Yamaguchi S., Ohtsuka R., Sasaki J., Tomita M., Kojima S., Takahashi N., Kashimoto Y., Kuwahara M., Takeda M., Kosaka T., Nakashima N., Harada T. Pulmonary injury and antioxidant response in mice exposed to arsenate and hexavalent chromium and their combination. Toxicology 2010, 267:118-124.
34. Tseng C.H., Chong C.K., Tseng C.P., Hsueh Y.M., Chiou H.Y., Tseng C.C., Chen C.J. Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan. Toxicol. Lett. 2003, 137:15-21.
35. Turan O., Akkoclu A., Coker C. Plasma LDH levels as a prognostic factor for evaluating stages and types of local advanced and metastatic NSCLC. J. Thorac. Oncol. 2007, 2.
36. Vahter M. Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity. Toxicol. Lett. 2000, 112-113:209-217.
37. Warner M.L., Moore L.E., Smith M.T., Kalman D.A., Fanning E., Smith A.H. Increased micronuclei in exfoliated bladder cells of individuals who chronically ingest arsenic-contaminated water in Nevada. Cancer Epidemiol. Biomarkers Prev. 1994, 3:583-590.
38. Watanabe C., Inaoka T., Kadono T., Nagano M., Nakamura S., Ushijima K., Murayama N., Miyazaki K., Ohtsuka R. Males in rural Bangladeshi communities are more susceptible to chronic arsenic poisoning than females: analyses based on urinary arsenic. Environ. Health Perspect. 2001, 109:1265-1270.